Amylgen’s murine model demonstrates the efficacy of RegenLife ’s device application for the treatment of Alzheimer’s disease Regenlife is opening doors to new treatment options for Alzheimer’s […]
Authors: Lahmy V1, Long R2, Morin D2, Villard V3, Maurice T1 1Inserm U 710, University of Montpellier 2 Montpellier, France ; Amylgen, Montferrier-sur-Lez France. 2Inserm […]